Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
An extra booster dose raised antibody levels in one third of people with organ transplants, but many remain unprotected.
Alcoholism-related liver disease was a growing problem even before COVID-19, but the pandemic has dramatically added to the toll.
The incidence rate is expected to be especially high among young women with alcoholic liver disease.
Researchers suggest the process is safe and may help reduce alcohol cravings.
People with advanced liver cirrhosis are at greater risk for severe COVID-19 illness and death.
Liver complications, heart disease and non-liver cancers also account for most deaths among people with hepatitis B or C.
The profile of chronic liver disease has changed due to obesity trends and advances in the treatment of hepatitis C.
Transplants due to hepatitis C have declined dramatically thanks to effective treatment.
Hepatitis B and C, non-alcoholic steatohepatitis (NASH) and alcohol-related liver disease are the main causes of liver cancer and cirrhosis.
Better treatments for hepatitis B and C and a lack of such advances for fatty liver or alcoholic liver disease are driving outcomes.
But experts advise caution, as the drug may worsen other liver diseases, including viral hepatitis.
From fatty liver disease to cirrhosis to alcoholic hepatitis—here’s what you need to know.
The biggest increases in alcohol-related deaths are among middle-aged women, according to a new study.
Alcohol-related liver disease is now the main reason for liver transplantation in the United States. The reasons for this are fascinating.
NPR’s “Fresh Air” recently interviewed Joshua Mezrich, MD, about what it’s like to save lives as a transplant surgeon.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.